Sexually Transmitted Diseases (STD) Treatment Market to Record a CAGR of 4.27%, Increasing Prevalence Of STDs to Boost Market Growth – Technavio – QNT Press Release

[ad_1]

NEW YORK, Oct. 5, 2022 /PRNewswire/ — The “Sexually Transmitted Diseases (STD) Treatment Market by Type (viral infections, bacterial infections, and other infections) and Geography (North America, Europe, Asiaand Rest of World (ROW)) – Forecast and Analysis 2022-2026″ report has been added to Technavio’s offering. North America will account for 44% of the market’s growth during the forecast period. This growth is attributed to factors such as the growing prevalence of STDs, the availability of drugs to treat STDs, and a strong presence of vendors such as Johnson and Johnson, Pfizer, AbbVie, and Abbott.

The potential growth difference for the sexually transmitted diseases (STD) treatment market size between 2021 and 2026 is USD 13.48 billion. To get the exact yearly growth variance and the YOY growth rate, Request a FREE PDF Sample Report

By type, the viral infections segment will be the largest contributor to market growth during the forecast period. This growth is driven by the rise in the prevalence of STDs caused by viruses. Some of the STDs caused by viruses include genital herpes (herpes simplex virus), genital infection (human papillomavirus), AIDS (HIV), and hepatitis B (hepatitis B virus).

View our FREE PDF sample report for additional insights into the contribution of all the segments and regional opportunities in the report

• Market Driver: The increasing prevalence of STDs is driving the growth of the market. STDs are caused by the transmission of various viruses, bacteria, and parasites. Some of the STDs include gonorrhea, syphilis, hepatitis B, chlamydia, genital herpes, and HIV/AIDS. Syphilis, chlamydia, gonorrhea , and trichomoniasis are curable. However, genital herpes, hepatitis B, HIV/AIDS, and STDs are caused by HPV and cannot be cured. The rising incidence and prevalence of STDs have increased the demand for the early screening and diagnosis of STDs. Vendors across the world are focusing on offering a wide range of STD treatment drugs. Hence, the rising incidence and prevalence of STDs in several countries globally are expected to foster the growth of the global STD treatment market.
• Market Trend: Advances in rapid diagnosis of STDs are a trend in the market. There is a significant shift from traditional laboratory testing to rapid point-of-care (POC) testing. The preference for self-testing for HIV has been growing rapidly across developed countries. Moreover, the market is witnessing Rapid advances in molecular diagnostics used in STD testing. Hence, the availability of advanced detection techniques is fueling the growth of the market. Moreover, the increasing research on biomarkers and recent advances are expected to ease the diagnosis process.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

• AbbVie Inc.
• Affymetrix
• Aurobindo Pharma Ltd.
• Becton Dickinson and Co.
• Bristol Myers Squibb Co.
• CH Boehringer Sohn AG and Co. KG
• Cepheid Inc.
• DiaSorin SpA
• Dynavax Technologies Corp.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Hologic Inc.
• Inovio Pharmaceuticals Inc.
• Johnson and Johnson
• Lee’s Pharmaceutical Holdings Ltd.
• Lupin Ltd
• Merck and Co. Inc.
• Mylan NV
• Pfizer Inc.

Want your report customized? Speak to an analyst and personalize your report according to your needs

Sexual Enhancement Supplements Market by Product and Geography – Forecast and Analysis 2022-2026: The sexual enhancement supplements market share is expected to increase by USD 801.29 million from 2021 to 2026.

Erectile Dysfunction (ED) Drugs Market by Product and Geography – Forecast and Analysis 2022-2026: The erectile dysfunction (ED) drugs market share is expected to increase by USD 1.20 billion from 2021 to 2026.

Full story available on Benzinga.com

[ad_2]

Source link